Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017616
Filing Date
2019-05-09
Accepted
2019-05-09 09:01:24
Documents
58
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-10q_20190331.htm 10-Q 1464038
2 EX-31.1 apvo-ex311_173.htm EX-31.1 19643
3 EX-31.2 apvo-ex312_172.htm EX-31.2 19475
4 EX-32.1 apvo-ex321_171.htm EX-32.1 10289
5 EX-32.2 apvo-ex322_170.htm EX-32.2 10397
  Complete submission text file 0001564590-19-017616.txt   4876761

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT apvo-20190331.xml EX-101.INS 770097
7 XBRL TAXONOMY EXTENSION SCHEMA apvo-20190331.xsd EX-101.SCH 50786
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20190331_cal.xml EX-101.CAL 41265
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20190331_def.xml EX-101.DEF 162431
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20190331_lab.xml EX-101.LAB 373473
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20190331_pre.xml EX-101.PRE 278733
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 19808998
SIC: 2834 Pharmaceutical Preparations